Accessing Capital in a Difficult Market: Strategic Growth Through Royalty Monetization and Revenue Interest Financing (Palo Alto Presentation) CANCELLED


Palo Alto

Stephen B. Thau

Stephen B. Thau


This program has been cancelled.

It is likely that the equity and debt markets will remain closed
throughout 2009 and into the foreseeable future to all but the largest
pharmaceutical, biotechnology, and medical device companies. How can the rest of the market access the capital needed to make the most of the growth opportunities?

Royalty monetization and revenue interest financing offer innovative companies attractive and available alternatives to their financing challenges. These financing vehicles can be tailored to meet a company's individual, near-term financial needs without the dilution associated with equity financing, the restrictive covenants of commercial debt, or the sacrifice of long-term value associated with product development partnerships.

Join your colleagues, Paul Capital Healthcare, and Morrison & Foerster LLP for an interactive discussion of how to put royalty monetization and revenue interest financing to work in achieving your corporate growth objectives.

Stephen B. Thau

Warren D. Cooper, President and Chief Executive Officer, Prism Pharmaceuticals, Inc.
John Leone, Partner, Paul Capital Healthcare
Kristian Wiggert, Morrison & Foerster LLP

This seminar will also be presented in San Diego.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.